These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 21723878

  • 1. Coagulant effects of black snake (Pseudechis spp.) venoms and in vitro efficacy of commercial antivenom.
    Lane J, O'Leary MA, Isbister GK.
    Toxicon; 2011 Sep 01; 58(3):239-46. PubMed ID: 21723878
    [Abstract] [Full Text] [Related]

  • 2. The efficacy of two antivenoms against the in vitro myotoxic effects of black snake (Pseudechis) venoms in the chick biventer cervicis nerve-muscle preparation.
    Ramasamy S, Isbister GK, Hodgson WC.
    Toxicon; 2004 Dec 15; 44(8):837-45. PubMed ID: 15530965
    [Abstract] [Full Text] [Related]

  • 3. Anticoagulant activity in Australasian elapid snake venoms and neutralisation with antivenom and varespladib.
    Murphy K, Tasoulis T, Dunstan N, Isbister GK.
    Toxicon; 2024 Aug 28; 247():107836. PubMed ID: 38945217
    [Abstract] [Full Text] [Related]

  • 4. Neurotoxic effects of venoms from seven species of Australasian black snakes (Pseudechis): efficacy of black and tiger snake antivenoms.
    Ramasamy S, Fry BG, Hodgson WC.
    Clin Exp Pharmacol Physiol; 2005 Aug 28; 32(1-2):7-12. PubMed ID: 15730427
    [Abstract] [Full Text] [Related]

  • 5. Cross-neutralisation of Australian brown and tiger snake venoms with commercial antivenoms: Cross-reactivity or antivenom mixtures?
    O'Leary MA, Schneider JJ, Krishnan BP, Lavis C, McKendry A, Ong LK, Isbister GK.
    Toxicon; 2007 Aug 28; 50(2):206-13. PubMed ID: 17467763
    [Abstract] [Full Text] [Related]

  • 6. Clinical implications of convergent procoagulant toxicity and differential antivenom efficacy in Australian elapid snake venoms.
    Zdenek CN, den Brouw BO, Dashevsky D, Gloria A, Youngman NJ, Watson E, Green P, Hay C, Dunstan N, Allen L, Fry BG.
    Toxicol Lett; 2019 Nov 28; 316():171-182. PubMed ID: 31442586
    [Abstract] [Full Text] [Related]

  • 7. Cross-neutralisation of the neurotoxic effects of Egyptian cobra venom with commercial tiger snake antivenom.
    Kornhauser R, Isbister GK, O'Leary MA, Mirtschin P, Dunstan N, Hodgson WC.
    Basic Clin Pharmacol Toxicol; 2013 Feb 28; 112(2):138-43. PubMed ID: 22788931
    [Abstract] [Full Text] [Related]

  • 8. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.
    Isbister GK, Woods D, Alley S, O'Leary MA, Seldon M, Lincz LF.
    Toxicon; 2010 Aug 01; 56(1):75-85. PubMed ID: 20338189
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Detection of venom-antivenom (VAV) immunocomplexes in vitro as a measure of antivenom efficacy.
    O'Leary MA, Isbister GK.
    Toxicon; 2014 Jan 01; 77():125-32. PubMed ID: 24252422
    [Abstract] [Full Text] [Related]

  • 12. The in vitro neuromuscular activity of Indo-Pacific sea-snake venoms: efficacy of two commercially available antivenoms.
    Chetty N, Du A, Hodgson WC, Winkel K, Fry BG.
    Toxicon; 2004 Aug 01; 44(2):193-200. PubMed ID: 15246769
    [Abstract] [Full Text] [Related]

  • 13. Clinical effects and treatment of envenoming by Hoplocephalus spp. snakes in Australia: Australian Snakebite Project (ASP-12).
    Isbister GK, White J, Currie BJ, O'Leary MA, Brown SG, ASP Investigators.
    Toxicon; 2011 Dec 01; 58(8):634-40. PubMed ID: 21967812
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies.
    Isbister GK, O'Leary MA, Schneider JJ, Brown SG, Currie BJ, ASP Investigators.
    Toxicon; 2007 Jan 01; 49(1):57-67. PubMed ID: 17055016
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The relative efficacy of chemically diverse small-molecule enzyme-inhibitors against anticoagulant activities of Black Snake (Pseudechis spp.) venoms.
    Chowdhury A, Youngman NJ, Liu J, Lewin MR, Carter RW, Fry BG.
    Toxicol Lett; 2022 Aug 01; 366():26-32. PubMed ID: 35788045
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy - Australian Snakebite Project (ASP-19).
    Johnston CI, Brown SG, O'Leary MA, Currie BJ, Greenberg R, Taylor M, Barnes C, White J, Isbister GK, ASP investigators.
    Clin Toxicol (Phila); 2013 Jun 01; 51(5):417-24. PubMed ID: 23586640
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.